Drugs / FLUBENTYLOSIN
FLUBENTYLOSIN
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04913610 | May 2021 → Aug 2023 | onchocerciasis | AbbVie | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUBENTYLOSIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4649378 ↗ |
| Known as | 4''-(p-fluorobenzyl)tylosin a | ChEMBL registry synonym — accepted as the source's own label CHEMBL4649378 ↗ |
| Known as | ABBV-4083 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04913610 ↗ |
| Modality | Small molecule | — CHEMBL4649378 ↗ |
| Route | Oral | “Oral Capsule” NCT04913610 ↗ |